Your browser doesn't support javascript.
loading
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
Nelson, Bryce J B; Andersson, Jan D; Wuest, Frank.
Affiliation
  • Nelson BJB; Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Ave, Edmonton, AB T6G 1Z2, Canada; Cancer Research Institute of Northern Alberta (CRINA), University of Alberta, Edmonton, AB T6G 2S2, Canada.
  • Andersson JD; Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Ave, Edmonton, AB T6G 1Z2, Canada; Cancer Research Institute of Northern Alberta (CRINA), University of Alberta, Edmonton, AB T6G 2S2, Canada; Edmonton Radiopharmaceutical Center, Cross Cancer Institute, Alberta Health Services, 11560 University Ave, Edmonton, AB T6G 1Z2, Canada.
  • Wuest F; Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Ave, Edmonton, AB T6G 1Z2, Canada; Cancer Research Institute of Northern Alberta (CRINA), University of Alberta, Edmonton, AB T6G 2S2, Canada. Electronic address: wuest@ualberta.ca.
Nucl Med Biol ; 110-111: 59-66, 2022.
Article in En | MEDLINE | ID: mdl-35487834
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Precision Medicine Language: En Journal: Nucl Med Biol Journal subject: BIOLOGIA / MEDICINA NUCLEAR Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Precision Medicine Language: En Journal: Nucl Med Biol Journal subject: BIOLOGIA / MEDICINA NUCLEAR Year: 2022 Document type: Article Affiliation country: Country of publication: